EATG » Scientific research

Scientific research

ABIVAX initiates clinical trial (ABX464-005) to evaluate the effect of ABX464 on HIV reservoirs in HIV patients

First patient enrolled The study seeks to unveil the biological mechanism of ABX464 behind the prolonged period before viral rebound occurs, seen in preclinical models Initial results are expected in…

New $1.5 million NIH grant targets oral complications of HIV

More than a third of HIV patients develop oral conditions from immune systems compromised by the virus and its treatment, according to the National Institutes of Health (NIH) While advances…

April 2017 issue of Journal of Virus Eradication now online

The April issue of the Journal includes papers on a range of topics and reports from three recent meetings: R4P; Glasgow HIV; and CROI 2017. To read an overview of the…

TAGline Spring 2017: A luta continua!

With every major election, particularly one that secures or fortifies Republican control of the White House, Senate, or House of Representatives, a certain amount of worry and strategy realignment is…

Grant to evaluate HIV immunotherapy PENNVAX®-GP’s ability to induce HIV remission

Inovio and collaborators receive NIH grant to evaluate HIV immunotherapy PENNVAX®-GP’s ability to induce remission of HIV infection and end lifetime of drug therapy Grant will fund therapeutic clinical studies…

‘On/off’ switch brings researchers a step closer to HIV vaccine

Innovation may make a vaccine candidate among safest yet reported By engineering an on/off switch into a weakened form of HIV, University of Nebraska-Lincoln researchers have enhanced the safety and…

New method to ‘fingerprint’ HIV developed

LA JOLLA, CA – March 28, 2017 – HIV is a master of disguise. The virus uses a shield of sugar molecules, called glycans, to hide from the immune system…

Penn Medicine AIDS researcher receives $16.3 million from National Institutes of Health to accelerate HIV vaccine development

Research aims to overcome difficulties in inducing HIV neutralizing antibodies PHILADELPHIA— Building on earlier work in designing  chimeric human-simian immunodeficiency viruses  (SHIVs) that serve as a model of HIV infection…

Hidden HIV reservoirs exposed by telltale protein

The discovery helps to identify dormant infected cells and could one day lead to a cure. Attempts to cure HIV have been thwarted by a particular type of immune-system cell…

Researchers map pathways to protective antibodies for an HIV vaccine

The findings advance progress toward HIV vaccine design DURHAM, N.C., March 15, 2017 – A Duke Health-led research team has described both the pathway of HIV protective antibody development and a…